July 23, 2013
1 min read

Growth equity firm launches Alphaeon to advance products in self-pay health care sector

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Lifestyle health care equity firm Strathspey Crown has established Alphaeon to help develop and commercialize technologies and services in ophthalmology, plastic surgery and dermatology, according to a news release. Alphaeon is the first-ever self-pay lifestyle health care corporation.

“Our vision is to encourage the development of forward-thinking medical advances that enhance patients’ lives,” Robert E. Grant, chairman and managing partner of Strathspey Crown, said in the release.

Alphaeon will be led by Grant, who will serve as CEO, and by William J. Link, PhD, who will serve as chairman.

Grant is a former president and CEO of Bausch + Lomb Surgical and former president of Allergan Medical. Link co-founded and serves as managing director of Versant Ventures. He also was founder, chairman and CEO of Chiron Vision.

Other company leaders with ophthalmic backgrounds include chief technology officer, David Mordaunt, PhD, a former CTO at Bausch + Lomb and former CEO of OptiMedica; chief physician officer, Daniel Durrie, MD; and chief marketing officer, Shareef Mahdavi.